Vibration-controlled transient elastography
Authors:
- 1 May 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 31 (3) , 192-198
Abstract
Therapeutic advances for hepatitis C and the increasing prevalence on nonalcoholic fatty liver disease are reshaping the diagnostic approach to disease staging in clinical hepatology. Well tolerated, inexpensive and reliable alternatives to liver biopsy are a critical need for clinicians and patients alike. Vibration-controlled transient elastography (VCTE, also known as 'transient elastography') is a robust, point-of-care tool for the noninvasive assessment of liver fibrosis. This tool efficiently prioritizes the treatment for patients with viral hepatitis at risk for advanced liver disease and identifies the subgroups with metabolic or cholestatic liver disease who are at the highest risk. Rather than staging fibrosis, VCTE provides an accurate risk estimate of advanced fibrosis. In addition, it is increasingly recognized that elastography can predict outcomes including hepatic decompensation and mortality. The ideal use of this tool is to perform it in conjunction with a serologic marker of fibrosis to confirm its findings. When combined with serologic markers of fibrosis, VCTE allows the vast majority of patients to avoid a liver biopsy.Keywords
This publication has 47 references indexed in Scilit:
- FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States PracticeClinical Gastroenterology and Hepatology, 2015
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 InfectionNew England Journal of Medicine, 2014
- Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinationsJournal of Hepatology, 2014
- Therapy for Hepatitis C — The Costs of SuccessNew England Journal of Medicine, 2014
- Utilization of FibroScan in Clinical PracticeCurrent Gastroenterology Reports, 2014
- The Feasibility and Reliability of Transient Elastography Using Fibroscan®: A Practice Audit of 2335 ExaminationsCanadian Journal of Gastroenterology and Hepatology, 2014
- Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994American Journal of Epidemiology, 2013
- Burden of Gastrointestinal Disease in the United States: 2012 UpdateGastroenterology, 2012
- Management of Nonalcoholic Fatty Liver DiseaseJAMA, 2012
- Liver BiopsyNew England Journal of Medicine, 2001